{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:11:53Z","timestamp":1783055513585,"version":"3.54.6"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Invest Radiol"],"published-print":{"date-parts":[[2024,9]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Unexpected accumulations of gadolinium in various organs were reported after the administration of gadolinium-based contrast agents, making desirable to reduce the dose while maintaining equivalent diagnostic performance. The aim of this study was to evaluate the contrast enhancement performance of high relaxivity gadopiclenol compared with gadoterate meglumine in abdominal contrast-enhanced magnetic resonance angiography (CE-MRA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods<\/jats:title>\n            <jats:p>In a first study in healthy rabbits, axial 3D gradient echo sequences were applied at 4.7 T to study arterial enhancement as a function of gadopiclenol dose (0.025, 0.05, 0.075, and 0.1 mmol Gd\/kg) or gadoterate meglumine at 0.1 mmol Gd\/kg (n = 5\u20136\/group). The increase in signal-to-noise ratio (\u0394SNR) in the aorta at the first pass was measured and compared. In a second, crossover study in 6 healthy pigs, abdominal CE-MRA sequences were acquired at 3 T with gadopiclenol at 0.05 mmol Gd\/kg or gadoterate meglumine at 0.1 mmol Gd\/kg at a 1-week interval. Quantitatively on the maximum intensity projection (MIP) images, the mean MIP SNR within the aorta of both groups was compared. Qualitatively, a blinded comparison of the angiograms was performed by an experienced radiologist to determine the preferred contrast agent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In the rabbit, \u2206SNR is linearly correlated with the gadopiclenol dose (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0010). Compared with gadoterate meglumine 0.1 mmol Gd\/kg, an increase in the \u2206SNR is observed after 0.05, 0.075, and 0.1 mmol Gd\/kg of gadopiclenol (+63% <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0731, +78% <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0081, and +72% <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0773, respectively), whereas at 0.025 mmol Gd\/kg, \u2206SNR is in the same range as with gadoterate meglumine 0.1 mmol Gd\/kg (+15% <jats:italic toggle=\"yes\">P<\/jats:italic> &gt; 0.9999). In pigs, contrast enhancement after gadopiclenol at 0.05 mmol\/kg is +22% superior to MIP SNR after gadoterate meglumine at 0.1 mmol Gd\/kg (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.3095). Qualitatively, a preference was shown for gadopiclenol images (3\/6) over the gadoterate meglumine examinations (1\/6), with no preference being shown for the remainder (2\/6).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>First-pass CE-MRA is feasible with gadopiclenol at 0.05 mmol Gd\/kg with at least the same arterial signal enhancement and image quality as gadoterate meglumine at 0.1 mmol Gd\/kg.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rli.0000000000001083","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T13:20:29Z","timestamp":1715001629000},"page":"614-621","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the Contrast Enhancement Performance of Gadopiclenol for Magnetic Resonance Angiography in Healthy Rabbits and Pigs"],"prefix":"10.1097","volume":"59","author":[{"given":"Ga\u00eblle","family":"Hugon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Adriaensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lody","family":"Wintrebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Serfaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"bib1-20250802","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-015-0275-4","article-title":"25 years of contrast-enhanced MRI: developments, current challenges and future perspectives","volume":"33","year":"2016","journal-title":"Adv Ther"},{"key":"bib2-20250802","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jmri.1880030614","article-title":"Dynamic gadolinium-enhanced three-dimensional abdominal MR arteriography","volume":"3","year":"1993","journal-title":"J Magn Reson Imaging JMRI"},{"key":"bib3-20250802","doi-asserted-by":"crossref","first-page":"209","DOI":"10.13104\/imri.2021.25.4.209","article-title":"Principles of magnetic resonance angiography techniques","volume":"25","year":"2021","journal-title":"Investig Magn Reson Imaging"},{"key":"bib4-20250802","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jmri.20005","article-title":"Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing, safety, and efficacy","volume":"19","year":"2004","journal-title":"J Magn Reson Imaging JMRI"},{"key":"bib5-20250802","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40261-018-0674-9","article-title":"Gadobutrol: a review in contrast-enhanced MRI and MRA","volume":"38","year":"2018","journal-title":"Clin Drug Investig"},{"key":"bib6-20250802","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.mri.2016.08.017","article-title":"Gadolinium based contrast agents (GBCA): safety overview after 3 decades of clinical experience","volume":"34","year":"2016","journal-title":"Magn Reson Imaging"},{"key":"bib7-20250802","first-page":"742","article-title":"Gadolinium in medical imaging-usefulness, toxic reactions and possible countermeasures\u2014a review","volume":"12","year":"2022","journal-title":"Biomol Ther"},{"key":"bib8-20250802","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","year":"2014","journal-title":"Radiology"},{"key":"bib9-20250802","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13244-019-0824-5","article-title":"Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats","volume":"11","year":"2020","journal-title":"Insights Imaging"},{"key":"bib10-20250802","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/RLI.0000000000000882","article-title":"Effect of contrast agent dose reduction on vascular enhancement and image quality in thoracoabdominal dynamic 3-dimensional magnetic resonance angiography: a systematic intraindividual analysis in pigs","volume":"57","year":"2022","journal-title":"Investig Radiol"},{"key":"bib11-20250802","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11547-014-0434-8","article-title":"Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?","volume":"120","year":"2015","journal-title":"Radiol Med (Turin)"},{"key":"bib12-20250802","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/RLI.0000000000000563","article-title":"Physicochemical and pharmacokinetic profiles of gadopiclenol: a new macrocyclic gadolinium chelate with high T1 relaxivity","volume":"54","year":"2019","journal-title":"Investig Radiol"},{"key":"bib13-20250802","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/RLI.0000000000000944","article-title":"Efficacy and safety of gadopiclenol for contrast-enhanced MRI of the central nervous system: the PICTURE randomized clinical trial","volume":"58","year":"2023","journal-title":"Investig Radiol"},{"key":"bib14-20250802","doi-asserted-by":"crossref","first-page":"e222612","DOI":"10.1148\/radiol.222612","article-title":"Efficacy and safety of half-dose gadopiclenol versus full-dose gadobutrol for contrast-enhanced body MRI","volume":"308","year":"2023","journal-title":"Radiology"},{"key":"bib15-20250802","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1006\/jsre.1995.1199","article-title":"Impedance cardiography in the measurement of cardiac output: studies in rabbits","volume":"59","year":"1995","journal-title":"J Surg Res"},{"key":"bib16-20250802","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.amjcard.2020.10.046","article-title":"Normative reference values of cardiac output by pulsed-wave Doppler echocardiography in adults","volume":"140","year":"2021","journal-title":"Am J Cardiol"},{"key":"bib17-20250802","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/RLI.0b013e3181852158","article-title":"Contrast-enhanced magnetic resonance angiography: evaluation of the high relaxivity low diffusible gadolinium-based contrast agent P846 in comparison with gadoterate meglumine in rabbits at 1.5 tesla and 3.0 tesla","volume":"43","year":"2008","journal-title":"Investig Radiol"},{"key":"bib18-20250802","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/mrm.10290","article-title":"MR angiography with a new rapid-clearance blood pool agent: initial experience in rabbits","volume":"48","year":"2002","journal-title":"Magn Reson Med"},{"key":"bib19-20250802","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/RCT.0b013e3181e359c2","article-title":"Three-dimensional multiphase time-resolved low-dose contrast-enhanced magnetic resonance angiography using TWIST on a 32-channel coil at 3 T: a quantitative and qualitative comparison of a conventional gadolinium chelate with a high-relaxivity agent","volume":"34","year":"2010","journal-title":"J Comput Assist Tomogr"},{"key":"bib20-20250802","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0730-725X(98)00012-5","article-title":"Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries","volume":"16","year":"1998","journal-title":"Magn Reson Imaging"},{"key":"bib21-20250802","first-page":"432","article-title":"A comparative anatomic and physiologic overview of the porcine heart","volume":"53","year":"2014","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"bib22-20250802","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00330-010-1940-2","article-title":"Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmolGd\/kg) in pigs at 1.5 tesla","volume":"21","year":"2011","journal-title":"Eur Radiol"},{"key":"bib23-20250802","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/jmri.23757","article-title":"MR angiography of carotid artery aneurysms in a porcine model at 3 tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques","volume":"36","year":"2012","journal-title":"J Magn Reson Imaging JMRI"}],"container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLI.0000000000001083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:05:28Z","timestamp":1754161528000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLI.0000000000001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rli.0000000000001083","relation":{},"ISSN":["1536-0210","0020-9996"],"issn-type":[{"value":"1536-0210","type":"electronic"},{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}